Three-year outcome of aflibercept treatment for Japanese patients with neovascular age-related macular degeneration

To evaluate the three-year outcome after intravitreal aflibercept injection (IAI) for neovascular age-related macular degeneration (nAMD).

Source: BMC Ophthalmology - July 10, 2020 Category: Opthalmology Authors: Kanako Itagaki, Tetsuju Sekiryu, Akihito Kasai, Yukinori Sugano, Masashi Ogasawara and Masaaki Saito Tags: Research article Source Type: research